Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normal and neoplastic stem cells.

Irving L Weissman1

  • 1Department of Pathology, Stanford University Medical Center, B257 Beckman Center, Stanford, CA 94305, USA.

Novartis Foundation Symposium
|July 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation of postnatal human neural stem cells.

bioRxiv : the preprint server for biology·2026
Same author

Xenophagocytosis blockade enhances interspecies chimerism.

Cell·2026
Same author

Somatic mutations reveal the ontogeny of human microglia.

bioRxiv : the preprint server for biology·2026
Same author

Polyclonal regeneration of mouse bone marrow endothelial cells after irradiative conditioning.

Cell reports·2026
Same author

Electrical stimulation promotes longevity and regeneration in a colonial chordate.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics.

Nature biotechnology·2026
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

Hematopoietic stem cells (HSCs) regenerate the blood system and can establish immune tolerance. However, HSCs do not transdifferentiate, and their self-renewal is key to understanding and treating cancers driven by cancer stem cells.

Area of Science:

  • Stem cell biology
  • Hematopoiesis
  • Cancer biology

Background:

  • Stem cells possess self-renewal and differentiation capabilities, distinguishing them from progenitors.
  • Hematopoietic stem cells (HSCs) are crucial for blood system regeneration after therapies like chemotherapy and radiotherapy.
  • HSCs offer a cancer-free alternative to bone marrow transplants, avoiding cancer cell re-seeding and enabling immune tolerance.

Purpose of the Study:

  • To investigate the regenerative capacity and potential plasticity of hematopoietic stem cells (HSCs).
  • To explore the role of stem cell self-renewal in cancer development, particularly in leukemias.
  • To differentiate between true stem cell properties and artifacts in previous research.

Main Methods:

  • Prospective purification of cancer-free hematopoietic stem cells (HSCs).

Related Experiment Videos

  • Assessment of HSC regenerative capacity in vivo.
  • Investigation of potential HSC transdifferentiation into non-hematopoietic cell types (muscle, heart, brain, gut).
  • Analysis of self-renewal pathways in myeloid leukemias and other tumors.

    • Main Results:

    • Purified HSCs demonstrated rapid and sustained regeneration of the hematopoietic system, comparable to transplants.
    • No evidence of HSC transdifferentiation into muscle, heart, brain, or gut cells was observed; cell fusion or purification issues were suggested as alternative explanations.
    • Dysregulated self-renewal of progenitor-stage cancer stem cells was identified as a driver in myeloid leukemias and other cancers.

    Conclusions:

    • Hematopoietic stem cells (HSCs) are essential for hematopoietic regeneration and can induce immune tolerance but lack transdifferentiation potential.
    • Cancer stem cells, characterized by aberrant self-renewal, are central to the pathogenesis of various cancers, including myeloid leukemias.
    • Understanding HSC self-renewal mechanisms is critical for both regenerative medicine and cancer therapy.